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Abstract
OBJECTIVES: To analyse the results of hybrid palliation of hypoplastic left heart syndrome (HLHS) patients and its variants with an
emphasis on the long-term fate of the pulmonary arteries.
METHODS: We analysed 28 neonates (2006–11) with HLHS and its variants, who underwent bilateral pulmonary artery banding, patent
ductus arteriosus (PDA) stenting and balloon atrial septostomy using a true hybrid approach. Median age and weight were 4 (0–36) days
and 3 (1.9–3.7) kg respectively. Diagnoses included 23 HLHS and 5 variants. The fate of all surviving branch pulmonary arteries (PA) after a
hybrid approach were compared with their counterparts in 29 Norwood I survivors (2002–11).
RESULTS: Four of 28 hybrid procedures needed to be converted to a Norwood procedure. Mortality after stage I hybrid palliation was
3/24 (12.5%). All 21 acute survivors underwent a comprehensive stage II at a median age of 4 (2.3–5.7) months, without any mortality (0%).
Eleven of 21 comprehensive stage II survivors have undergone extracardiac Fontan; including 1 who underwent a rescue Fontan at 7 months
of age and died (1/11: 9%). While 18/21 (86%) needed branch PA intervention in the hybrid group during the median follow-up duration of
39 (10–81) months, 9/29 (31%) needed the same in the Norwood group during a median follow-up duration of 58 (16–128) months
(P < 0.001). Eight of 21 (38%) needed stenting [all on the left pulmonary artery (LPA)] in the hybrid group vs 5/29 (17%) in the Norwood group
(P = 0.097). Ten of 21 (48%) patients had surgical/catheter intervention on both branch PA in the hybrid group vs 2/29 (7%) in the Norwood
group (P = 0.001). Pre-Fontan Nakata index was signiﬁcantly better in the Norwood group 206 (118–406) compared with the hybrid group
153 (56–230) mm2/m2 (P = 0.01). The comparable lower lobe indices were 149 (103–333) and 137 (45–178) mm2/m2 (P = 0.04), respectively.
CONCLUSIONS: Hybrid approach can be pursued with a low mortality. However, the high frequency of catheter and/or surgical interven-
tions, and the sluggish growth of the branch PA pre-Fontan need innovative solutions. A comparison of the neurodevelopmental outcome
for the hybrid vs the Norwood cohort would deﬁne the role of the hybrid strategy in the treatment of HLHS and its variants.
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INTRODUCTION
When left untreated, 95% of the children with hypoplastic left
heart syndrome (HLHS) die early. Since the 1980s, surgical options
have become available. Multidisciplinary advancements have
improved outcomes tending to a survival of 65% at 5 years and
55% at 10 years of age [1]. Till very recently, there were basically
two main surgical approaches: (i) the staged univentricular
pathway with a Norwood operation in the early neonatal period,
followed by a bidirectional Glenn at 3–6 months of age and an
extracardiac Fontan completion between 18 and 30 months of
age. (ii) Primary cardiac transplantation.
Despite encouraging surgical outcomes in pursuing the staged
univentricular pathway, it was clear that the end result achieved
remained at best a palliation with need for lifelong medical atten-
tion. Many of the survivors with optimal outcome had substantial
developmental issues and health problems later in life—putting
enormous strain on the family and the society at large.
Considering that in addition to pre-existing intranatal develop-
mental anomalies of the brain, a complex intracardiac repair in
the early neonatal period involving hypothermia, regional cere-
bral perfusion or even circulatory arrest may be harmful in the
long run, a hybrid approach was developed. The goal of this ap-
proach was to postpone the complex correction to a later time.
Although ﬁrst described in the early 1990s by Gibbs et al. [2], it
was reinvented by Akintuerk et al. [3] in 2002. This strategy†The ﬁrst two and the last two authors contributed equally to this paper.
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involved interventional patent ductus arteriosus (PDA) stenting,
followed by bilateral pulmonary artery banding (BPAB) through a
sternotomy. This approach has since been adopted by various
centres like Toronto [4], Delaware [5] and Ohio [6] and individua-
lized. We introduced the hybrid approach for HLHS in 2006 [7].
This report analyses our experience with the hybrid approach in
28 HLHS patients or its variants (2006–11).
MATERIALS ANDMETHODS
We analysed 28 neonates (2006–11) who underwent BPB, PDA
stenting and balloon atrial septostomy using a single stage true
hybrid approach. Institutional review board permission was
obtained to conduct this retrospective study. Median age and
weight were 4 (0–36) days and 3 (1.9–3.7) kg, respectively.
Diagnoses included 23 HLHS patients and 5 variants.
Contraindications
Since 2006, the hybrid approach has been our preferred ap-
proach. However, very small ascending aorta (≤2 mm) and sten-
osis of the arch anywhere upstream from the aortic isthmus were
considered as relative contraindications for the hybrid approach.
In one of the patients with arch obstruction detected after the
hybrid procedure, a reverse modiﬁed Blalock–Taussig (BT) shunt
from the main pulmonary artery to the truncus brachiocephalicus
was performed, which served to reinforce the cerebral and coron-
ary circulation (Fig. 1). Ventriculocoronary connection coexisting
with aortic atresia and complete retrograde perfusion was
considered a relative contraindication for a hybrid approach;
however, we did subject one such patient to a hybrid procedure.
As a rule, we would subject such a patient to a Norwood proced-
ure with a right ventricle-pulmonary artery (RV-PA) shunt, thus
improving diastolic blood pressure, making it possible to suture
close the mitral valve thus reducing steal, and optimising post-
capillary pulmonary venous ﬂow.
Procedure
The decision for a hybrid approach came during a combined car-
diology–cardiac surgery consensus meeting. The procedure was
performed in the catheter laboratory.
Through a sternotomy approach, BPAB was performed ﬁrst.
Depending on the size of the branch PA, a Gore-Tex graft
(W. L. Gore & Associates, Inc., AZ, USA) 3–3.5 mm was ordered. A
3 mm long ring of the said graft was prepared. The Gore-Tex
ring was split open at the blue dotted line and implanted at the
origin of the branch pulmonary arteries (PA). The ring was closed
using interrupted 7.0 polypropylene stitches. The ring was also
ﬁxed to the adventitia of the main pulmonary artery. Since the
right pulmonary artery (RPA) was often bigger than the left pul-
monary artery (LPA), the banding was titrated accordingly. The
origin of the LPA was more difﬁcult to circumvent, because of the
dilated main pulmonary artery.
Banding both branch PA resulted in improvement of systemic
blood pressure as well as a fall in arterial saturation. A saturation of
80% with an inspired oxygen concentration of 50% was aimed
at. In some cases, an additional constriction of the Gore-Tex ring
was effected, by placing a mattress absorbable suture; with the
idea that the absorption of the suture could potentially compen-
sate for the growth of the child. No pressure measurement across
the banding site was performed. Median weight of patients re-
ceiving 3.5 mm Gore-Tex banding ring (n = 13) was 3.2 (2.6–3.8)
kg; median weight of patients receiving 3.0 mm Gore-Tex banding
ring (n = 5) was 3.1 (2.7–3.4) kg; in 6 patients the band size was not
available.
Subsequently the interventional procedure was performed. A
4-French sheath was inserted across a purse-string placed on the
body of the right atrium (Fig. 2). The sheath was marked at 1.5 cm
from the tip (with a silk ligature) to guide the insertion (1 cm).
The position of the purse-string was aimed in such a way that it
provided a linear access to the tricuspid valve. The interventional car-
diology team performed PDA stenting using balloon expandable
stents. A balloon dilatation of the atrial septal defect (ASD) was also
performed in the same setting. Following completion of the proced-
ure, the sternum was closed. Figure 3 shows the PDA stents and the
BPAB in situ at the end of the hybrid procedure. The patients were
subjected to quick weaning and extubation was aimed at within 24 h.
Comprehensive stage II and extracardiac
Fontan completion
The comprehensive stage II procedure was planned at 3 months
of age. All intracardiac repairs were performed using cardiopul-
monary bypass (CPB) and antegrade cerebral perfusion under
moderate hypothermia. The duct was transacted from the pul-
monary artery; the stent material lodged in the duct was removed
in toto. The Damus-Kaye-Stansel anastomosis was performed and
the aortic arch enlarged with Xeno-pericardium or a pulmonary
Figure 1: A reverse modiﬁed Blalock–Taussig shunt between main pulmonary
artery and truncus brachiocephalicus demonstrating retrograde perfusion of
the ascending aorta.
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homograft. The PA bands were removed. In general, while the
LPA-banding site was only dilated using Hegar’s dilator, the
RPA-banding site was enlarged while performing the bidirectional
Glenn anastomosis. Extracardiac Fontan completion was per-
formed between 24 and 36 months of age.
Long-term fate of pulmonary arteries after
hybrid approach
Long-term fate (pre-Glenn and pre-Fontan) of the surviving
branch PAs after a hybrid procedure were compared with those
after 29 Norwood I procedure survivors (2002–11). Nine non-
survivors after the Norwood I procedure during this time frame
were excluded from this comparison, since they did not provide a
substrate for comparing the long-term fate of the branch PAs. The
median follow-up observation period for the hybrid group was 39
(10–81) months as against 58 (16–128) months for the Norwood I
survivors.
RESULTS
Conversion
In 4/28 (14.3%) patients, the hybrid approach was converted to a
Norwood I procedure at day 0, 15, 42 and 85 due to ASD stent
dislodgement, morphological factors (such as residual gradient
across the isthmus) or haemodynamic factors.
Early events
In 2 patients with a restrictive foramen ovale and a thick atrial
septum not yielding to balloon septostomy, an atrial septectomy
using CPB and placement of BPAB was performed. In 1 patient the
right atrial purse-string tore through, leading to dislodgement of
the sheath and severe bleeding. The child could be resuscitated
and stabilized and the intervention pursued to completion.
Late events
Stenosis of the aortic isthmus area necessitated balloon dilatation
in 1 patient and stenting in 2 patients.
Other interventions performed include closure of left sided ver-
tical vein (veno-venous collateral vein) and opening up of fenes-
tration due to high Fontan pressure in 1 patient each.
Mortality
Overall mortality was 4/24 (17%), 3 after the hybrid stage I proced-
ure (32, 12 and 43 days) and 1 after a rescue Fontan at 7 months
of age. The cause of deaths included arrhythmias in 1 and occlu-
sion of the LPA with a failing Fontan in 1; the cause remained
unknown in 2 cases. The mortality reduced with experience and
was 1/12 (8%) in the second half of the series. Kaplan–Meier sur-
vival at 60 months was 83 ± 8% for the hybrid group.
Revision of PA banding
Revision of banding was necessary in 5 of 25 cases; once to
tighten it and four times to loosen it. Loosening was most often
accomplished with a balloon dilatation while tightening was per-
formed surgically.
Comprehensive stage II and stage III extracardiac
Fontan completion
Twenty-one acute survivors underwent a comprehensive stage II
without early mortality at a median of 4 (2.3–5.7) months of age.
Figure 2: Intraoperative picture of the true hybrid procedure: transatrial sheath
in situ for performing PDA stenting and balloon atrial septostomy.
Figure 3: PDA stents and bilateral branch PA bands seen in situ.
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Eleven of 21 survivors have undergone extracardiac Fontan com-
pletion; one of them being a rescue Fontan at 7 months of age,
who eventually died (1/11: 9%). This child suffered occlusion of
the LPA after comprehensive stage II, which was treated with a
left-sided BT shunt and eventually with a rescue Fontan, of which
she succumbed after a protracted course.
Duration of ventilation and hospital stay
The median duration of ventilation after hybrid stage I, compre-
hensive II and stage III extracardiac Fontan completion were 4, 3
and 1 days, respectively; the corresponding median hospital stay
were 46, 43 and 25 days, respectively.
Fate of branch pulmonary arteries
A limited comparison of the post-Norwood branch PAs compared
with post-hybrid branch PAs was made. Only 3 of 21 survivors
remained free of any intervention on the branch PAs after the
hybrid approach. Eighteen of 21 (86%) survivors needed branch
PA reconstruction (6 patients) and/or catheter intervention (12
patients) in the hybrid group; 9/29 (31%) survivors in the
Norwood group required the same; this was highly signiﬁcant
(P < 0.001) (Table 1). Need for branch PA stenting although
showing a trend, was not signiﬁcantly different between the
hybrid group [8/21 (38%)] and the Norwood group [5/29 (17%)]
(P = 0.097). All stenting were needed on the LPA. Ten of 21 (48%)
patients needed bilateral PA (surgical or interventional) procedure
in the hybrid group vs 2/29 (7%) patients in the Norwood group
(P = 0.001) (Table 2).
Pulmonary artery indices
A comparison of the pulmonary artery indices for the hybrid as
well as the Norwood group are given in Table 3.
DISCUSSION
After an initial learning curve [8], the overall results for the conven-
tional Norwood – Fontan pathway strategy have continued to
Table 1: Branch pulmonary arteries surgical reconstruction and/or catheter intervention
Any branch PA surgery/intervention (number of
patients)
Total
No Yes
Hybrid group
n 3 18 21
% Within group 14% 86% 100%
Norwood group
n 20 9 29
% Within group 69% 31% 100%
Total
n 23 27 50
% Within group 46% 54% 100%
P < 0.001 (excludes early death patients).
Table 2: Bilateral branch pulmonary arteries surgical reconstruction and/or catheter intervention
Bilateral branch PA surgery/intervention (number
of patients)
Total
No Yes
Hybrid group
n 11 10 21
% Within Group 52% 48% 100%
Norwood group
n 27 2 29
% Within group 93% 7% 100%
Total
n 38 12 50
% Within group 76% 24% 100%
P = 0.001 (excludes early death patients).
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improve [9–10]. While the survival has improved to 74–93%, the
inter-stage I–II mortality has continued to be a problem [11–14].
The use of RV–PA shunt [8] as well as introduction of home moni-
toring of transcutaneous oxygen saturation have somewhat alle-
viated this risk [15]. With the early survival improving, the impact
of the complex neonatal operation and its consequences on the
late neurodevelopmental outcome, have become the subject of
increasing debate [9, 16].
It has been reported that patients with HLHS completing the
staged Fontan pathway have signiﬁcant neurocognitive difﬁculties
[17]. A part of the neurocognitive deﬁciency is attributed to the
structural abnormalities pre-existing in the brain of these patients
[18]. Many studies have established a direct correlation between
aortic atresia (complete retrograde perfusion of the arch) and
poor late neurodevelopmental outcome [7, 19]. Magnetic reson-
ance imaging studies have shown that neonates who undergo
complex congenital heart surgery have a 34% increase in periven-
tricular leukomalacia and non-speciﬁc signs of cerebral white
matter injury [20]. It has thus been hypothesized that neonates
with HLHS have a fragile central nervous system to begin with;
and when subjected to an early neonatal repair under CPB (often
with deep hypothermia and circulatory arrest) can lead to or ag-
gravate neurological injury [21].
Operational issues
A hybrid approach has been pursued recently [3], with a view to
postponing the complex intracardiac repair to a later age. Apart
from the neurological advantage, it is argued that this strategy is
useful for centres offering primary neonatal heart transplantation,
where the potential recipient must wait long for getting a match-
ing donor heart. This palliation can achieve stability and even
allow discharge to home. This approach eliminates shunt-related
complications. Additionally, in patients with borderline hypoplasia
of left heart structures, this approach may buy time to see if the
left heart structures grow big enough to allow a biventricular
repair. Various groups described modiﬁed sequences and tech-
niques of performing BPAB and PDA stenting [5, 6]. We have
adopted a single stage true hybrid approach, with catheter inter-
vention performed transatrially. This approach saves the femoroi-
liac venous system from potential postinterventional hazards. The
BPAB are placed directly at the origin of the branch PA.
Mortality and morbidity
Kaplan–Meier survival at 5 years in our experience was 83 ± 8% for
the hybrid group. Although not strictly comparable (cohorts), the
5-year survival in our Norwood group was 75.7 ± 7% (P = 0.5). In
the Toronto experience, the corresponding survival at 3 years was
65.1% for the hybrid group and 58.9% for the Norwood group
(P = 0.7) [4]. Akintuerk et al. [3] (Giessen, Germany) reported a
transplant-free survival of 7/11 (64%) through to the comprehen-
sive stage. Galantowicz et al. [6] (Ohio, USA) showed a transplant
free survival of 32/40 (80%). Four of 32 survivors needed LPA stent
and no patient needed PA augmentation during stage III, which
are stand out results. This is in contrast with our ﬁndings and that
of the Toronto group with increased incidence of banding-site
interventions, most often on the LPA [4] as well as lower Nakata
and lower lobe indices at the pre-Fontan stage.
Fate of the pulmonary arteries
The size and the quality of branch PAs and the arborization down-
stream is very important for the long-term outcome of the Fontan
circulation. With our results echoing those from the Toronto
group, we are worried at the frequency of interventions required
on the branch PA.
We have observed that the banding site on the branch PA does
not always recover spontaneously after debanding and simple
dilatation with an olive tipped probe. It needs to be enlarged, oc-
casionally even from one hilum to the other. How much does this
extensive patching impinge on the long-term growth of the pul-
monary arteries is open to debate.
The need for stenting (all on the LPA) in nearly 40% of our
patients is a cause for additional concern, since the stent inserted
in infancy cannot be dilated to adult size—meaning thereby that it
needs to be cut through or replaced. Replacement even during a
Fontan procedure is an invasive procedure ridden with risks. The
stent ﬁxes the branch PA to a static non-compliant state, which of
course is advantageous when an external compression by a large
neo-aorta is suspected. We wonder if the high incidence of
banding site interventions that we have observed, could be
related to tighter banding or reluctance to outright patch the pul-
monary arteries during the comprehensive stage II.
In contrast, the lower rate of interventions on branch PA
post-Norwood – Fontan pathway and better PA growth indices
nearly 2 years after having corrected them (either with patches or
stents) calls for technical modiﬁcations to ensure growth in the
hybrid group patients.
Hospital resources
With the mortality rate after the hybrid approach being compar-
able with the Norwood approach, the hybrid approach may be
Table 3: Comparison of branch pulmonary arteries indices
Hybrid group mm2/m2 Norwood group mm2/m2 P-value
Pre-Glenn Nakata index 124 (46–236) 172 (94–437) 0.011
Pre-Glenn lower lobe index 103 (42–459) 169 (91–354) 0.003
Pre-Fontan Nakata index 153 (56–230) 206 (118–406) 0.014
Pre-Fontan lower lobe index 137 (45–178) 149 (103–333) 0.04
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potentially advantageous in terms of reduced hospital resource
utilization (duration of Intensive care unit and hospital stay) [6].
Neuroprotection
In spite of a few factors for and against the hybrid strategy, it is the
much hypothesized neuroprotective advantage that will be the
deciding factor regarding the long-term role of this approach.
A comprehensive study of neurodevelopment at 1 year com-
paring our hybrid and Norwood cohorts [7] has not shown statis-
tically signiﬁcant advantage for the hybrid group. In view of the
wide variability of the CPB and hypothermia protocols used in
centres around the world, results about the neurodevelopment
outcome would have to be interpreted factoring in the inﬂuence
of the bypass strategy used during the arch reconstruction
operation.
LIMITATIONS
This report bears all the limitations inherent in a retrospective
analysis. Moreover, the hybrid and Norwood groups are strictly
not comparable since the more complex patients are likely to
have been assigned to undergo the Norwood procedure.
CONCLUSION
Hybrid approach can be pursued with mortality comparable with
the Norwood procedure. The need for interventions on the
branch PAs as well as their reduced growth at the pre-Fontan time
point, is a cause for concern, where technical improvements need
to be evolved. However, it will be the long-term neurodevelop-
mental outcome results, which will determine the role of the
hybrid approach in the treatment of HLHS and its variants.
Conﬂict of interest: none declared.
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